Journal of Pharmaceutical Investigation最新文献

筛选
英文 中文
Nanomedicine-based commercial formulations: current developments and future prospects. 基于纳米医学的商业配方:目前的发展和未来前景。
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2023-01-01 DOI: 10.1007/s40005-022-00607-6
Raj Kumar Thapa, Jong Oh Kim
{"title":"Nanomedicine-based commercial formulations: current developments and future prospects.","authors":"Raj Kumar Thapa,&nbsp;Jong Oh Kim","doi":"10.1007/s40005-022-00607-6","DOIUrl":"https://doi.org/10.1007/s40005-022-00607-6","url":null,"abstract":"<p><strong>Background: </strong>In recent decades, there has been a considerable increase in the number of nanomedicine-based formulations, and their advantages, including controlled/targeted drug delivery with increased efficacy and reduced toxicity, make them ideal candidates for therapeutic delivery in the treatment of complex and difficult-to-treat diseases, such as cancer.</p><p><strong>Areas covered: </strong>This review focuses on nanomedicine-based formulation development, approved and marketed nanomedicines, and the challenges faced in nanomedicine development as well as their future prospects.</p><p><strong>Expert opinion: </strong>To date, the Food and Drug Administration and the European Medicines Agency have approved several nanomedicines, which are now commercially available. However, several critical challenges, including reproducibility, proper characterization, and biological evaluation, e.g., via assays, are still associated with their use. Therefore, rigorous studies alongside stringent guidelines for effective and safe nanomedicine development and use are still warranted. In this study, we provide an overview of currently available nanomedicine-based formulations. Thus, the findings here reported may serve as a basis for further studies regarding the use of these formulations for therapeutic purposes in near future.</p>","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"19-33"},"PeriodicalIF":5.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10472499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. 经鼻给药途径给药脑:关键靶点和主要考虑因素的探索。
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2023-01-01 DOI: 10.1007/s40005-022-00589-5
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
{"title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors.","authors":"Seung-Hyun Jeong,&nbsp;Ji-Hun Jang,&nbsp;Yong-Bok Lee","doi":"10.1007/s40005-022-00589-5","DOIUrl":"https://doi.org/10.1007/s40005-022-00589-5","url":null,"abstract":"<p><strong>Background: </strong>Cranial nerve-related diseases such as brain tumors, Alzheimer's disease, and epilepsy are serious diseases that continue to threaten human. Brain-related diseases are increasing worldwide, including in the United States and Korea, and these increases are closely related to the exposure to harmful substances and excessive stress caused by rapid industrialization and environmental pollution. Drug delivery to the brain is very important for the effective prevention and treatment of brain-related diseases. However, due to the presence of the blood-brain barrier and the extensive first-pass metabolism effect, the general routes of administration such as oral and intravenous routes have limitations in drug delivery to the brain. Therefore, as an alternative, the nasal-brain drug delivery route is attracting attention as a route for effective drug delivery to the brain.</p><p><strong>Areas covered: </strong>This review includes physiological factors, advantages, limitations, current application status, especially in clinical applications, and the necessary factors for consideration in formulation development related to nasal-brain drug delivery.</p><p><strong>Expert opinion: </strong>The nasal-brain drug delivery route has the advantage of enhancing drug delivery to the brain locally, mainly through the olfactory route rather than the systemic circulation. The nasal-brain lymphatic system has recently attracted attention, and it has been implied that the delivery of anticancer drugs to the brain nervous system is possible effectively. However, there are limitations such as low drug permeability, as well as nasal mucosa and the mucociliary system, as obstacles in nasal-brain drug delivery. Therefore, to overcome the limitations of nasal-brain drug delivery, the use of nanocarriers and mucoadhesive agents is being attempted. However, very few drugs have been officially approved for clinical application via the nasal-brain drug delivery route. This is probably because the understanding of and related studies on nasal-brain drug delivery are limited. In this review, we tried to explore the major considerations and target factors in drug delivery through the nasal-brain route based on physiological knowledge and formulation research information. This will help to provide a mechanistic understanding of drug delivery through the nasal-brain route and bring us one step closer to developing effective formulations and drugs in consideration of the key factors for nasal-brain drug delivery.</p>","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"119-152"},"PeriodicalIF":5.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10481642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients 通过药物赋形剂抑制药物代谢酶和转运体来调节底物药物的药代动力学
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-12-20 DOI: 10.1007/s40005-022-00606-7
Min‐Koo Choi, Jihoon W. Lee, I. Song
{"title":"Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients","authors":"Min‐Koo Choi, Jihoon W. Lee, I. Song","doi":"10.1007/s40005-022-00606-7","DOIUrl":"https://doi.org/10.1007/s40005-022-00606-7","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"1-18"},"PeriodicalIF":5.5,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45056805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Quality by design approach with multivariate analysis and artificial neural network models to understand and control excipient variability 采用多元分析和人工神经网络模型的设计质量方法来理解和控制赋形剂的变异性
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-12-20 DOI: 10.1007/s40005-022-00608-5
J. Y. Kim, D. Choi
{"title":"Quality by design approach with multivariate analysis and artificial neural network models to understand and control excipient variability","authors":"J. Y. Kim, D. Choi","doi":"10.1007/s40005-022-00608-5","DOIUrl":"https://doi.org/10.1007/s40005-022-00608-5","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"389-406"},"PeriodicalIF":5.5,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44572131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Peptide permeation enhancers for improving oral bioavailability of macromolecules 提高大分子口服生物利用度的肽渗透增强剂
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-12-20 DOI: 10.1007/s40005-022-00609-4
Dohyun Kim, Lan Jin, Eun Ji Park, D. Na
{"title":"Peptide permeation enhancers for improving oral bioavailability of macromolecules","authors":"Dohyun Kim, Lan Jin, Eun Ji Park, D. Na","doi":"10.1007/s40005-022-00609-4","DOIUrl":"https://doi.org/10.1007/s40005-022-00609-4","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"59-72"},"PeriodicalIF":5.5,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43537851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Digestive enzyme supplementation in prescription drugs, over-the-counter drugs, and enzyme foods 处方药、非处方药和酶食品中的消化酶补充剂
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-12-14 DOI: 10.1007/s40005-022-00605-8
Hyun Jung Park, H. Lee
{"title":"Digestive enzyme supplementation in prescription drugs, over-the-counter drugs, and enzyme foods","authors":"Hyun Jung Park, H. Lee","doi":"10.1007/s40005-022-00605-8","DOIUrl":"https://doi.org/10.1007/s40005-022-00605-8","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"343 - 355"},"PeriodicalIF":5.5,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48860133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complexation of levocetirizine with ion-exchange resins and its effect on the stability of powder mixtures containing levocetirizine and montelukast 左西替利嗪与离子交换树脂的络合作用及其对含左西替利嗪和孟鲁司特粉末混合物稳定性的影响
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-12-07 DOI: 10.1007/s40005-022-00604-9
HyeogJin Park, Su Hyun Seok, E. Park
{"title":"Complexation of levocetirizine with ion-exchange resins and its effect on the stability of powder mixtures containing levocetirizine and montelukast","authors":"HyeogJin Park, Su Hyun Seok, E. Park","doi":"10.1007/s40005-022-00604-9","DOIUrl":"https://doi.org/10.1007/s40005-022-00604-9","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"377-388"},"PeriodicalIF":5.5,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49101348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets 肠溶右雷贝拉唑片处方研制及药动学评价
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-11-23 DOI: 10.1007/s40005-022-00602-x
Tae-Jin Lee, Dohyun Kim, J. Kim, Simpson Ro, D. Na
{"title":"Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets","authors":"Tae-Jin Lee, Dohyun Kim, J. Kim, Simpson Ro, D. Na","doi":"10.1007/s40005-022-00602-x","DOIUrl":"https://doi.org/10.1007/s40005-022-00602-x","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"323-331"},"PeriodicalIF":5.5,"publicationDate":"2022-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47389105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A quality by design approach in oral extended release drug delivery systems: where we are and where we are going? 口服缓释给药系统的质量设计方法:我们在哪里,我们将走向何方?
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-11-18 DOI: 10.1007/s40005-022-00603-w
A. Sousa, J. Serra, C. Estevens, R. Costa, A. Ribeiro
{"title":"A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?","authors":"A. Sousa, J. Serra, C. Estevens, R. Costa, A. Ribeiro","doi":"10.1007/s40005-022-00603-w","DOIUrl":"https://doi.org/10.1007/s40005-022-00603-w","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"269-306"},"PeriodicalIF":5.5,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46964548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Nanomedicine approaches for medulloblastoma therapy 纳米药物治疗成神经管细胞瘤
IF 5.5 4区 医学
Journal of Pharmaceutical Investigation Pub Date : 2022-11-16 DOI: 10.1007/s40005-022-00597-5
Chaemin Lim, Jain Koo, K. Oh
{"title":"Nanomedicine approaches for medulloblastoma therapy","authors":"Chaemin Lim, Jain Koo, K. Oh","doi":"10.1007/s40005-022-00597-5","DOIUrl":"https://doi.org/10.1007/s40005-022-00597-5","url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"53 1","pages":"213 - 233"},"PeriodicalIF":5.5,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45878558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信